AUTL
Autolus Therapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$2.24
−2.18%Margins
Gross margin
15.7%
EBITDA margin
-188.7%
EBIT margin
-210.8%
Net margin
-238.6%
FCF margin
-202.3%
-374.2%
Return on equity
-56.8%
Return on assets
-156.2%
Return on invested capital
0.23x
Asset turnover
-$225.6M
Cash from operations
$0.76
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026